Balanitis xerotica obliterans

ICD-10 N48.0 · ICD-11 EB60.1

BXO with Phimosis in Boys Under 18: Management After Clobetasol Propionate Ointment Has Not Resolved Phimosis

This protocol addresses boys under 18 years of age with balanitis xerotica obliterans (BXO) who present with phimosis and in whom an initial course of topical corticosteroid therapy did not achieve resolution.

Clinical Scenario

Patient is a boy under 18 years with BXO and co-existing phimosis. Phimosis has persisted despite first-line topical treatment, meeting the threshold for escalation to the next line of care.

Prior Treatment — Goal Not Achieved

The first-line approach used clobetasol propionate ointment applied topically. The required outcome — resolution of penile phimosis within 1 to 3 months — was not achieved, making escalation to the current protocol appropriate.

Next-Line Approach

When topical therapy fails, guidelines recommend referral to a pediatric urologist for a definitive surgical procedure. The specific intervention and full clinical pathway are detailed in the structured protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1111/ijd.14236

In boys, the same guidelines suggest that those with phimosis be referred to a pediatric urologist for circumcision following 1–3 months of failed TCS.

View source ↗